Veterinarians are familiar with the wide range of regenerative therapies available for equine use. PRP kits, bone marrow aspirates, and hyaluronic acid (HA) injections have long been mainstays. But each comes with trade-offs. PRP and BMAC require time-consuming on-site preparation and offer results that vary based on sample quality. HA is easy to administer but tends to break down quickly, offering limited long-term protection.
Maintain Performance Under Pressure
StrideGuard was developed to bridge this gap. It combines the convenience of HA with the biologic power of ECM-rich tissue. Unlike PRP, StrideGuard does not rely on the horse’s own blood or bone marrow. Unlike polyacrylamide products, it doesn’t just fill space. It actively supports healing and lubrication. With its viscoelastic, shear-thinning behavior, StrideGuard mimics healthy synovial fluid and maintains performance under pressure, giving equine professionals a smarter tool for joint recovery and protection.